Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Dage

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Neurobiology of Disease|June 7, 2012
Constitutive secretion of tau protein by an unconventional mechanismXiyun Chai, Jeffrey L Dage, Martin Citron
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 6, 2025
The National Centralized Repository for Alzheimer's Disease and Related Dementia's Biomarker Assay Laboratory: A Resource for the Alzheimer's Disease Research CommunityKristen A Russ, Kaci Lacy, Jeffrey L Dage, et al.
EMBO Molecular Medicine|December 3, 2021
Blood-based biomarkers for Alzheimer's diseaseAntoine Leuzy, Niklas Mattsson-Carlgren, Sebastian Palmqvist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2020
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body DiseaseSara Hall, Shorena Janelidze, Elisabet Londos, et al.
Acta Neuropathologica Communications|January 7, 2022
Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levelsMalin Wennström, Shorena Janelidze, K Peter R Nilsson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults with Blood Biomarkers pTau217, GFAP, NfL, and Aβ ratioAna W Capuano, David A Bennett, Jeffrey L Dage, et al.
Brain : a Journal of Neurology|June 2, 2021
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjectsJoana B Pereira, Shorena Janelidze, Erik Stomrud, et al.
Neurology|September 8, 2021
Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 AssaysAntoine Leuzy, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisTatiana M Foroud, Kelley M Faber, Kaci Lacy, et al.
Neurology|October 28, 2025
Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults With Blood Biomarkers pTau217, GFAP, NfL, and Aβ RatioAna W Capuano, David A Bennett, Jeffrey L Dage, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Neurobiology of Disease|June 7, 2012
Constitutive secretion of tau protein by an unconventional mechanismXiyun Chai, Jeffrey L Dage, Martin Citron
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 6, 2025
The National Centralized Repository for Alzheimer's Disease and Related Dementia's Biomarker Assay Laboratory: A Resource for the Alzheimer's Disease Research CommunityKristen A Russ, Kaci Lacy, Jeffrey L Dage, et al.
EMBO Molecular Medicine|December 3, 2021
Blood-based biomarkers for Alzheimer's diseaseAntoine Leuzy, Niklas Mattsson-Carlgren, Sebastian Palmqvist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2020
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body DiseaseSara Hall, Shorena Janelidze, Elisabet Londos, et al.
Acta Neuropathologica Communications|January 7, 2022
Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levelsMalin Wennström, Shorena Janelidze, K Peter R Nilsson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults with Blood Biomarkers pTau217, GFAP, NfL, and Aβ ratioAna W Capuano, David A Bennett, Jeffrey L Dage, et al.
Brain : a Journal of Neurology|June 2, 2021
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjectsJoana B Pereira, Shorena Janelidze, Erik Stomrud, et al.
Neurology|September 8, 2021
Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 AssaysAntoine Leuzy, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisTatiana M Foroud, Kelley M Faber, Kaci Lacy, et al.
Neurology|October 28, 2025
Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults With Blood Biomarkers pTau217, GFAP, NfL, and Aβ RatioAna W Capuano, David A Bennett, Jeffrey L Dage, et al.
Pageof 13